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Nonribosomal peptides (NRP) are highlighted in pharmacological studies as novel NRPs
are often promising substances for new drug development. To effectively discover novel
NRPs from microbial fermentations, a crucial step is to identify known NRPs in an early
stage and exclude them from further investigation. This so-called dereplication step ensures
the scarce resource is only spent on the novel NRPs in the following up experiments.
Tandem mass spectrometry has been routinely used for NRP dereplication. However, few
bioinformatics tools have been developed to computationally identify NRP compounds
from mass spectra, while manual identification is currently the roadblock hindering the
throughput of novel NRP discovery.
In this thesis, we review the nature of nonribosomal peptides and investigate the chal-
lenges in computationally solving the identification problem. After that, iSNAP software
is proposed as an automated and high throughput solution for tandem mass spectrometry
based NRP identification. The algorithm has been evolved from the traditional database
search approach for identifying sequential peptides, to one that is competent at handling
complicated NRP structures. It is designed to be capable of identifying mixtures of NRP
compounds from LC-MS/MS of complex extract, and also finding structural analogs which
differ from an identified known NRP compound with one monomer. Combined with an
in-house NRP structural database of 1107 compounds, iSNAP is tested to be an effective
tool for mass spectrometry based NRP identification.
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Nature has the power to craft an almost infinite number of unique and effective molecules.
Among natural molecules produced by living organism, many have been discovered with
a diverse sphere of bioactivities, such as antibiotics, immunosuppressants, toxins, and
etc.[1]. These are certainly interesting properties that suggest pharmaceutical potentials.
Over decades, bioactive natural products are highlighted in pharmaceutical studies as they
are promising substances for drug development[2], and are also utilized to understand bio-
chemical mechanisms[3]. According a review article published in Science Magazine in 2009
[4], approximately 50% of all new drug approvals in the past 25 years either come from
natural products and their variants, or are semi-synthetics, which are synthesized using
natural compounds as starting materials. (Figure 1.1)
Within the category of natural products, nonribosomal peptides (NRP) are a family of
small molecules that are naturally produced as secondary metabolites by microorganisms.
Optimized through natural selection, many nonribosomal peptides have been evolved to fit
specific functions in certain biological processes. As secondary metabolites, nonribosomal
peptides are not directly necessary in an organism’s growth cycle, but often have a vital
impact on the organism’s continuing existence in adverse situations and play important
roles in interspecies defense.
As such, nonribosomal peptides are always targeted in the frontier of the search for
therapeutic agents. In the battle with infection diseases, the demand for powerful antibi-
otics is substantial. Vancomycin[5] (Figure 1.2), which is a nonribosomal peptide, was
1
Figure 1.1: Number of drugs approved in the United States from 1981 to 2007. [4]
discovered and isolated in 1953. It was used but no longer capable as our last line of
defense, as bacteria and pathogenic organisms are continuously evolving and building up
resistance. Under the threat of “super bugs” infection, new drugs have been developed,
including daptomycin[6], which originated from nonribosomal peptides. The need for ad-
vancing antibiotics discovery is real and urgent, and nonribosomal peptides are naturally
a promising pool of candidates.
The range and scope of drugs that have been developed from nonribosomal peptides
are also vast. In the antibiotics category, besides vancomycin, more NRP compounds have
been developed to be approved drugs, such as gramicidins[7] and polymyxins[8]. Other
than antibiotics, cyclosporine-A[9], rapamycin[10], are isolated to be an immunosuppres-
sant drug, widely used in organ transplant to reduce the risk of rejection. As cytostatics,
bleomycin[11], epothilone[12] and related analog compounds are developed to be anticancer
agents in clinical treatment of various type of cancers. Figure 1.2 shows the molecular struc-
tures of some of the NRPs mentioned above. Overall, approximately 5% of 205 grouped
families of nonribosomal peptides have become clinically approved drugs[13].
Beyond those nonribosomal peptides which are already known, more research efforts
























Figure 1.2: Samples structures of nonribosomal peptides as approved drugs.
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new NRP structures and novel NRP analogs are targeted, as they could possibly be candi-
dates or leads for new drug development. As for the methods, researchers tend to choose
newly found microbial strains for fermentation screening, as they are more likely to pro-
duce unknown natural products. In a typical screening, microbial strains are cultured
under various conditions, and often stressed with heat or ethanol shock to hopefully trig-
ger the expression of biosynthetic genes that encoded for nonribosomal peptide synthetases
(NRPS). Fermentations are screened for bioactivity with liquid chromatograph (LC), and
tandem mass spectrometry (MS/MS) is then applied to interrogate the structural infor-
mation of compounds in bioactive fractions. In the event that promising compounds exist,
such compounds are then purified to allow structural confirmation with nuclear magnetic
resonance spectroscopy (NMR).
Unfortunately, nonribosomal peptide discovery increasingly results in reconfirmation of
known compounds. This highlights the importance of identifying known NRP compounds
in an early stage and excluded them from further studies. This process is also referred as
dereplication[4]. Dereplication with mass spectrometry is consider to be a cost competitive
practice, since it only requires small amounts of compound mixed within the fermentation
extracts. Conversely, the stages after mass spectrometry are time consuming and expensive.
For instance, structural confirmation with NMR consumes expensive reagents and also
purified analyte[15], which is laborious to prepare, and the effort could be wasted if the
compound turns out to be a known NRP.
However, manual NRP dereplication is laborious at this moment even with mass spec-
trometry. To manually identify NRP from tandem mass spectra, each spectrum is exam-
ined and compared with standard spectra of NRPs collected from literature. Such method
is inefficient, because the number of spectra can be hundreds when dereplicating with
LC-MS/MS data acquired from microbial extract. Moreover, given the fact that there is
currently no census NRP spectral library as reference, experimental spectra are only com-
pared to a limited number of standard NRP spectra. This either requires a good knowledge
of anticipated NRPs[14] in order to selectively construct the set of standard spectra, or
would simply miss a hit.
Nonribosomal dereplication is time consuming and currently the roadblock hindering
the throughput of novel NRP discovery. An automated solution that confidently identi-




For more than a decade, computational methods have become popular for the analysis
of mass spectrometry data. Multiple database search algorithms have been successfully
developed for linear peptide identification with tandem mass spectrometry. These algo-
rithms computationally link MS/MS data back to the corresponding peptides in a protein
database, thus reveal the structural information. We believe the workflow could be simi-
larly adopted to nonribosomal peptides (Figure 1.3). A NRP database search algorithm is
need to fill in the gap, which links MS/MS spectra of nonribosomal peptides to the correct
structure in an NRP database.
In this research, the primary objective is to invent a database search algorithm that
practically solves the dereplication problem for nonribosomal peptides, by computationally
identifying NRPs from tandem mass spectra.
Specifically, the solution need to be practical with the following requirements satisfied:
• Usefulness
– The solution should to be capable of identifying NRPs from either purified
sample or within complex microbial extract at low abundance (µg/ml).
– NRP identifications should be interpretable and associated with consistently cal-
culated statistical scores. The statistical scores should truthfully help make the
decision whether an NRP exists in the sample, thus advance the dereplication
process.
– A comprehensive database with a decent number of NRPs need to be provided
along with the search algorithm.
• Correctness
– NRPs with similar structure should be distinguishably identified by the algo-
rithm. In other words, a spectrum must be precisely identified as the correct
one when the database contains multiple NRPs of similar structures.
– Identifications made by the algorithm should have a low false discovery rate.
Tandem mass spectra of substances outside of the database should not be mis-
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Figure 1.3: Workflow of MS/MS based nonribosomal peptides dereplication. Microbial
fermentation with bioactivity is analyzed using an LC-MS system. With data dependent
acquisition or pre-determined acquisition window, ionized compounds in the complex mix-
ture are selected and then fragmented in tandem mass spectrometry. For each selected
precursor ion, an MS/MS spectrum is generated with detected fragment ions. In such
an experiment, the number of MS/MS spectra can be hundreds. Software is needed to
compare those MS/MS spectra with a database of discovered NRPs, so that known NRPs
in the fermentation can be identified and excluded from further studies.
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It is common that a family of structurally similar NRPs can be produced simultaneously
in the same microbial fermentation[16]. Tyrocidines, as an example, are only different at
a few amino acid residues (Figure 1.4). When a known NRP is identified, it becomes more
likely to find novel analogs coexisted in the same data set.
To take advantage of the given fact, we aim to expand the algorithm be an informatics
tool for novel analog discovery. Precisely, we define analog as an NRP which is not in the
database but only different at a small number of k building blocks to a database NRP,
where a building block is the structural component between two adjacent amide bonds. As
a secondary objective, we design the algorithm to be capable of identifying NRP analogs
with k = 1. When it identifies an analog, it should indicate the original database NRP,
from which the analog is derived, and also locate the position of the different building
block.
Finally, the invented algorithms need to be implemented as software tools that can be
easily used by wet-lab researchers to assist daily analysis of NRP deprelication.
1.3 Thesis Overview
The thesis is structured in the following chapters. In Chapter 2, we briefly review the
nature of nonribosomal peptides, analyze their associated characteristics that prevent tra-
ditional identification algorithms from being applicable. The computational challenges for
developing an NRP identification algorithm is then discussed. After that we review the
pioneering works in the general topic of NRP identification. In Chapter 3, we first propose
the design of iSNAP, the nonribosomal peptides database search algorithm, and demon-
strate the underlying scoring scheme using bacitracin-A as an example. An experiment
is then performed to determine the appropriate score thresholds. After that, the iSNAP
algorithm is progressively challenged with a series of experiments, by which the algorithm’s
performance is analyzed. Chapter 4 illustrates the design and experiments for the analog
search algorithm, which is proposed to be an expansion to iSNAP database search. In
Chapter 5, we compile a list of conceivable projects that can be derived from this research,
including new strategies for nonribosomal peptide identification and an innovative ways of










As the name suggests, nonribosomal peptides are a class of peptides that are not directly
synthesized by ribosomes. In the synthesis of a ribosomal peptide, gene sequence is first
transcribed to messenger RNA (mRNA), which serves as a template that carries the genetic
information encoding the peptide. The template is then binded by ribosomes, which read
the information and assemble the peptide. At ribosomes, transfer RNA (tRNA) recognizes
codons from the mRNA and brings in the corresponding amino acid. Every codon is a
short sequence consists of three nucleotides. A codon either encodes for one of the 20
proteinogenic amino acids, or functions as the indicator of the peptide terminal. The chain
of translated amino acid are then assembled in ribosomes to form a linear peptide.
Nonribosomal peptides can be easily differentiated from its ribosomal counterpart.
Structurally, a ribosomal peptide is essentially a chain of amino acids linked by amide
bonds. The amino acids, as a sequence, form a linear peptide backbone. However, non-
ribosomal peptides have much more diverse structures, often having a non-linear peptide
backbone which is cyclic, branching, or a combination of the two[17]. As an example in Fig-
ure 2.1, bacitracin-A showcases the cyclization of amino acids. The C-terminal of peptide
backbone connects with the side chain of a lysine residue and forms an amide bond. The
cyclization leaves bacitracin-A a cyclic component as well a linear branch. More complex
structures also exist, such as vancomycin, which has multiple cyclic components.
Nonribosomal peptides are also more complex in monomer composition. Ribosomal





Figure 2.1: Molecular structure of bacitracin-A is distinct from that of ribosomal peptides.
(1) Bacitracin-A contains an ornithine residue. Ornithine, as a non-proteinogenic amino
acid, is not encoded by DNA. (2) Macrocyclization of the peptide backbone connects the
C-terminal with the side chain of a lysine residue. The cyclization leaves bacitracin-A a
cyclic component as well a linear “tail”.
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modifications. Nonribosomal peptides have many more types of monomers, which are not
limited to proteinogenic amino acids. In NORINE database [13], more than 500 monomers
in nonribosomal peptides have already been documented. On top of that, modifications
are more commonly observed with nonribosomal peptides [18], which further increase the
monomer diversity.
Back in 1960s, these peculiar features were observed in biochemical studies and implied
that mechanisms other than ribosomal pathway is involved in the synthesis[19]. Experi-
ments were designed to test the hypothesis, and it was confirmed with the observation that,
even with the presence of RNAses or other inhibitors of ribosomal biosynthesis, natural
production of theses compounds can still occur.
More comprehensive knowledge in synthesis of nonribosomal peptides was revealed
with in-depth biochemical experiments in the 2000s[20]. The synthesis of nonribosomal
peptides is directly facilitated by one or more nonribosomal peptide synthetases (NRPS),
which are a type of specialized proteins. NRPSs are multi-enzyme complexes and vary in
size, ranging from 10K Da to 1.6M Da. They are modularized in functionality. During
the synthesis of nonribosomal peptides, each NRPS serves a particular role, specifically, as
the initiation module, the elongation module or the termination module. It is noteworthy
that NRPSs are not only the machinery for the synthesis, but also the template to deter-
mine the monomers in nonribosomal peptides. The synthesized linear peptide undergoes
cyclization and further modifications before becoming the final product[18]. This pathway
helps explain the incorporation of structural features in nonribosomal peptides.
It is noticed that NRPS is similar to polyketide synthetases (PKS) to a certain ex-
tent. NRPS and PKS can both be involved in a biosynthesis process, which resulting
in compounds with mixed NRP and polyketide components[21]. This is observed in
Epothilone[12], and is common in many secondary metabolites. Consequently, this fur-
ther increases the structural complexity in nonribosomal peptides.
2.2 Computational Challenges for NRP identification
Before the investigation of challenges for NRP identification, computational methods for
linear peptide identification is briefly reviewed. The quick review helps answer the question
that, to what extent these traditional algorithms can inspire or resemble an algorithm for
solving the problem of NRP identification.
For more than a decade, bioinformatics tools have become indispensable in mass spec-
trometry data analysis. Since the development of the SEQUEST algorithm in 1994 [22],
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which is the first computational method to correlate tandem spectra and peptide sequences,
multiple algorithms have been developed to identify linear peptides from tandem mass
spectra, and some successfully commercialized. At present, the most popular software in-
clude Mascot[23], PEAKS[24], and X!Tandem[25], to name a few. With the capability to
confidently identify a large number of peptides from complex proteomic data with decent
sensitivity and accuracy, these software have been widely used in laboratories for scientific
research.
Even though the goal is generally the same, different approaches are developed for linear
peptide identification. Generally, algorithms can be characterized into three categories,
database search, de novo sequencing, and spectral library search.
Database search is the most common approach. A database search algorithms identifies
peptides by matching tandem spectra with hypothetical spectra of sequential peptides in
a protein database. The hypothetical spectrum is generated by the algorithm on-the-fly,
based on the amino acid sequence and fragmentation rules. As an example, with collision-
induced dissociation[26, 27], which is a very common mechanism to fragment molecules in
mass spectrometry, bond breakages mostly occur at amide bonds, resulting in b-ions and
y-ions as the most abundant fragment ions (See Figure 2.2). Other fragment ions, such
as a-ions and “satellite” ions with further loss of NH3 or H2O, are often observed as well.
Following these rules, fragments can be generated in-silico, and the collection of mass-to-
charge (m/z) ratios of these fragments become a hypothetical spectrum. The algorithm
generate scores that indicates how well a tandem spectrum is explained by a hypothetical
spectrum. Generally, when a good number of significant peaks in a tandem spectrum are
matched, the score is high, then an identification is made. SEQUEST, PEAKS, Mascot,
X!Tandem are software tools using database search approach for peptide identification.
Database search has been proven to be successful with the capability to identify a
large number of peptides from complex proteomic data. However, this method requires a
protein database that defines the search space. Without further design, it cannot detect
unexpected peptides, for example, those with modifications or mutations. It is also not
applicable in the situation that there is no database for the analyzed sample.
De novo sequencing is an approach that directly analyzes peak transitions in the tan-
dem spectrum, and derives a best matching peptide, in most cases, composed with 20
proteinogenic amino acids. Since the search space is not limited by any database, de novo
sequencing can identify peptides with mutations, or those from unknown genomes. PEAKS
is currently the one of the state-of-the-art software in peptide de novo sequencing[29] and
is commercially available. Other de novo sequencing software includes Lutefisk[30] and
PepNovo[31].
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Figure 2.2: Typical fragmentation pattern of ribosomal peptides in collision-induced dis-
sociation. [28]
Spectral library search is an alternative to database search. Instead of using hypothet-
ical spectra generated from peptide sequence, tandem spectra are matched with a library
of real spectra. The sequence of these library spectra are previously determined during the
compilation of the library. Therefore, an identification is made when a tandem spectrum is
matched by a library spectrum. Overall, library search is faster than database search, since
it skips the step of in-silico fragmentation. It often generates identifications with better
accuracy, because library spectra not only provides the realistic information on fragments’
mass-to-charge ratios but also ion intensities. At this moment, the shortcoming of this
approach is the limited coverage and availability of spectral libraries. However, library
search is deemed as a promising approach, as comprehensive spectral libraries of peptides,
such as PeptideAtlas [32], are being constructed with expanding coverage across human,
mouse, yeast, and several other organisms.
For all three approaches, scoring is always an important component in a peptide iden-
tification algorithm. Scores are indicators about how well a spectrum represents a peptide.
and they also facilitate ranking peptide candidates to find the best match for a spectrum.
A scoring scheme distinguishes true identifications from random matches, and is the core
component of any algorithm. Such a score can be directly calculated based on matched
peaks. However, such a straightforward score is often not comparable across the identifica-
tions on different spectra. It is therefore more usable if the reported scores are calculated
with statistical methods, so that a significance meaning can be established.
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Unfortunately, these traditional algorithms are only designed to identify linear peptides,
and not applicable to nonribosomal peptides which often have complex structures with
cyclic and/or branching backbone. We assume that an NRP identification algorithm can
be developed using at lease one of the above proven approaches, as suggested by similarity
between the two problems. However, the following challenges must be addressed before an
approach can be successfully adapted for NRP identification.
The first challenge is the data representation of structures, In traditional algorithms,
linear peptides are represented as strings of amino acids. Each amino acid is stored as a
single letter code. Using strings as the data structure, in silico fragmentation is a very
natural process, in which a string is spitted sequentially at each position. Each time, two
fragments are generated as the substrings from the cleavage site to either one of the string
terminals. However, such a simple string is not adequate to represent a nonribosomal
peptide with complex structures or having non-peptide components. We argue that an
encoding system need be used, which preserves the structural information. It should be
easy to store, and also friendly to computational analysis.
Secondly, other than the data structure, the algorithm itself is also challenged by NRP’s
structural complexity. For a database search algorithm, in-silico fragmentation is needed.
As demonstrated in Figure 2.3, if the pure cyclic structure is only dissociated at one amide
bond at a time, as it is done for linear peptides, the resulting fragments are going to be
different versions of linearized peptide cycle, and have the exact same mass[33]. This is
nearly useless in revealing structural information. Therefore, fragments generated with
further dissociation on these linearize peptides, which also known as internal fragments,
are more crucial for a successful identification of NRP structures.
As for de novo sequencing, algorithms have been developed with the assumption of
linear structure. It would be a difficult problem to accurately reconstruct the complex
structure of an NRP with sub-sequences derived from peak transitions in a spectrum.
However, even sub-sequences are hard to be figured out as NRPs can be composed of more
than 500 types of monomers, rather than the 20 proteinogenic amino acids. This drastically
increases the search space, and make the traditional de novo sequencing algorithms not
usable.
The third challenge concerns the availability of NRP database or NRP spectral library.
A database or library indispensably defines the search space of the the algorithm. For
spectral library search, although the matching algorithms are intrinsically applicable to
any spectra, including spectra of NRPs, the approach is hindered by the absence of NRP
spectral library. Currently, there is no NRP spectral libraries available. Though many labs
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Figure 2.3: The figure demonstrates the linearization of a purely cyclic nonribosomal
peptide. Using the fragmentation rule for ribosomal peptides, the cyclic structure is only
dissociated at one amide bond at a time, leaving different versions of linearized fragments.
These fragments have the same amino acid composition, but the amino acid residues are in
assorted orders as the result of different cleavage site. With identical mass, the fragments
cannot be differentiated by mass spectrometers, therefore cannot provide any structure
information.
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these spectral sets are usually small in size, have varying quality, and may not be available
to the public.
Fortunately, data availability is much less an issue for structural database search, which
only need to molecular structures of NRPs to search with. Norine [13], as a comprehensive
database specialized for NRPs, has been freely available since 2008. Besides that, NRP
structures can be collected from the small molecules databases in PubChem. Collecting
NRP structures takes substantially less efforts than compiling a spectral library.
With the consideration of the above challenges, we conclude that database search is
comparably the most feasible approach for solving the NRP identification problem. In the
developing of an NRP database search algorithm, a workflow can be similarly established,
with special efforts in addressing the challenges in data representation, in-silico fragmen-
tation and database preparation. Moreover, a new robust scoring scheme is needed, which
should efficiently distinguish true and false matches between experimental spectra and
hypothetical spectra generated from NRP structures.
2.3 Related Work in NRP identification
In spite of the fact that NRP related informatics research is still in its infancy, there
are already a number of pioneering works that laid the foundation for solving the NRP
identification problem. We review some of these works in this section, and comment on
their contributions and limitations.
2.3.1 Tandem Mass Spectra Interpretation of Cyclic NRPs
In 2009, Liu. etc [34] proposed the program MS-CPA, which annotates tandem mass
spectra obtained with collision-induced dissociation from cyclic NRPs. The program takes
an NRP structure and a spectrum as the input. It annotates the spectrum by highlighting
peaks that are matched by the fragment ions derived from the structure. It is known that
the complexity of NRP structures consequently increases the complexity of the resulting
tandem mass spectrum. Knowing the structure, manually annotating a tandem spectrum
can still be a difficult task. It was demonstrated that the program was capable of annotating
seglitide and tyrocidines, and was used to confirm the sequence of two newly discovered
NRPs, desmethoxymajusculamide-C and dudawalamide-A
In the development of MS-CPA, it was noticed that up to 15% of major peaks in a spec-
trum can not be explained by fragments generated from the corresponding NRP structure.
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With further investigation, they realized that some of these unanticipated fragments could
be explained by first scrambling the monomers in the cyclic peptide backbone before any
known fragmentation rules were applied. It was truly unanticipated but was just a con-
firmation to the bizarre fragmentation behavior of NRPs. These unusual fragments were
first described by Harrisons et al. in 2006 [35], as non-direct sequence (NDS), distinguished
from direct sequence (DS) fragmented by traditional rules.
The program facilitates the elucidation of tandem spectra, and helps understand the
fragmentation behavior of cyclic NRPs. However, the program is not a solution for NRP
identification. The annotation requires an NRP structure as an input, assuming it is
the correct one. No scoring is built on top of the annotation, thus we cannot use it
to rank the annotations on a spectrum using different NRP as candidates. Besides, the
program is limited to cyclic NRPs with a perfect cyclic backbone without any other complex
components, thus, not applicable to the majority of NRPs.
2.3.2 De Novo Sequencing of Cyclic NRPs
Pioneering work by Ng et al. [36] has initially tackled the de novo sequencing problem
for cyclic NRPs, which was considered much more challenging than database search. A
de novo sequencing algorithm using MS3 spectrum was proposed and demonstrated to be
successful in reconstructing cyclic NRPs. Although the algorithm only aimed to solve the
problem for perfectly cyclic NRPs, the problem was still difficult. For a cyclic NRP, the
amide bonds in the cycle are potentially opening sites. In the stage of MS2, with collision
energy carefully controlled, each precursor ion of cyclic NRP is fragmented at only one
amide bond. The breakage generates different linearized versions of the cyclic peptide[33],
as illustrated in Figure 2.3, and no other fragments. These linearized versions have the
same mass and undergo further fragmentation in MS3. Thus, the MS3 spectrum essentially
appears as the superposition of internal fragment ions from each linearized peptide. The
MS3 spectrum contains more structural information than the MS2, but it is difficult to
interpret.
To sequence the cyclic NRP, the proposed algorithm first extracts a list of most preva-
lent peak transitions in the MS3 spectrum by using spectral auto-convolution. The tech-
nique was commonly used in signal processing for finding repeating patterns, such as
periodic signals buried under noise, and was introduced to mass spectrometry analysis by
Pevzner et al. in 2000 [37]. This step reveals the amino acid composition, as prevalent
peak transitions are most likely corresponding to mass of monomers in the NRP. Then, a
heuristic algorithm uses these mass values as the “alphabet” to align sub-sequences and
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reconstruct the most probable NRP. In this way, the algorithm does not need to use a
pre-defined monomer set, such as the 20 proteinogenic amino acids. Therefore, it avoids
the problem caused by enormous types of monomers in NRPs.
The algorithm performed excellently in sequencing tyrocidines, cyclosporin and sur-
factin, and was marked as a significant step in bioinformatics research for NRPs. However,
the de novo sequencing algorithm was specifically designed for purely cyclic NRPs, which
are not applicable to the majority of NRPs. Moreover, the algorithm was only tested
with purified samples, and the mass spectrometer was specifically optimized for the tested
NRPs in order to generate clean fragmentation. It limits the algorithm’s usability as a
practical tool for NRP dereplication, where complex extract need to be processed in high
throughput.
2.3.3 NORINE: A Database of Nonribosomal Peptides
NORINE is the first and most comprehensive database dedicated to nonribosomal pep-
tides [13]. The NORINE project started in 2008 as a collaboration project between the
SEQUOIA bioinformatics research group of LIFL (Laboratoire d’Informatique Fondamen-
tale de Lille), INRIA (Institut National de Recherche en Informatique et en Automatique)
and the NRPS team of ProBioGem laboratory. The objective is to provide a versatile
platform that enables research in nonribosomal peptides. Such a platform includes a doc-
umented NRP database as well as tools for browsing. The NORINE database started with
around 700 NRP entries, and is continuously growing ever since. Up to the year of 2010,
the database already consists of 1122 NRPs, grouped into 205 families. Each NRP entry
is comprehensively annotated with information of its structure, bioactivities, origins and
so on. The NORINE website provides a set of tools, including structural pattern search
which allows users to search for NRPs with a particular substructure.
NORINE database is a freely accessible to researchers. It sets a solid foundation for
the development of database search algorithms. However, for unknown reasons, the NRP
database has not been updated in the last two years. There are newly discovered NRP




iSNAP for Nonribosomal Peptide
Database Search
3.1 Method Overview
iSNAP is proposed as a bioinformatics tool to aid and assist in the dereplication of
nonribosomal peptide (NRP) compounds from complex mixtures. The program has evolved
from the traditional database search approaches, which are strictly applied to sequential
peptides, to one capable of identifying complicated peptide structures. It has been designed
to identify NRPs which may have cyclic and branching structures.
Figure 3.1 outlines the three components of iSNAP. The first is the structural NRP
database. It contains 1107 nonribosomal peptides, and ultimately defines what can be
possibly identified with the algorithm. For each collected compound, a list of possible
fragment ions is generated and stored. We refer the list as the hypothetical spectrum,
which is used to match with the input MS/MS spectra. The second component is the
algorithm for NRP database search. A scoring scheme is designed to evaluate the matches
between input MS/MS spectra and hypothetical spectra of NRPs in database. Significance
scores are calculated for each match and enable the identification of NRPs. The third
component is the algorithm for NRP analog search. This component is an extension to
the database search algorithm. It utilizes the identified NRPs in database search as seeds,
and re-analyzes the input MS/MS spectra to find analogs to a seed NRP with structural
difference at one building block. The first two components, the database and the search
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Figure 3.1: Workflow of NRP database search with iSNAP. As pre-computation, iSNAP
generates hypothetical spectra of structures in the NRP database based on multiple cleav-
ages at amide bonds. In the process of NRP identification, the noise peaks in input MS/MS
spectra are first filtered. iSNAP analyzes each input MS/MS spectrum, either within LC-
MS/MS acquired by data dependent acquisition or simply within a list of MS/MS scans.
It scores the input MS/MS spectrum with the hypothetical spectrum of structures in the
NRP database. Two scores, P1 and P2 are calculated for each input MS/MS spectrum,
indicating the significance of the best matching NRP structure. If both scores are above
their corresponding thresholds, the best matching structure is reported as an identified
NRP and linked to the MS/MS spectrum.
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3.2 Structural Database
3.2.1 Collection of Nonribosomal Peptides
A in-house database of nonribosomal peptides was collected by research collabora-
tors from Nathan Magarvey Lab at McMaster University. In constructing this database,
nonribosomal peptide were collected from the NORINE database[13], PubChem and the
Journal of Antibiotics. Structures were first reconstructed in Chemdraw software and then
converted to SMILES code[38]. SMILES stands for Simplified Molecular Input Line Spec-
ification, which is a standard encoding system that represents chemical molecules into a
linear string while preserving all the structural information. The database is formatted in
text files, where name and SMILES code of each compound are stored in pairs, and allows
the algorithm to load efficiently.
The SMILES format is parsed by iSNAP and converted to a graph which stores atoms
and bonds as vertices and edges, respectively. Represented by graph data structure, nonri-
bosomal peptides can be annotated computationally by iSNAP, which identifies the linear,
cyclic and cyclic-branching components. Furthermore, peptide backbone in a molecule is
also annotated through amide bonds, providing linkage information of monomer blocks.
In total, the database consists of 1107 compounds, produced mostly by nonribosomal
peptide synthetases. The mass distribution of database compounds is shown in Figure 3.2.
Besides that, it is worth to mention that iSNAP allows researchers to upload a series of
SMILES codes to be included into the database for dereplication or to fulfill their specific
research purposes.
3.2.2 In Silico Fragmentation and Hypothetical Spectra
iSNAP processes the SMILES code of each NRPs to create the corresponding hypo-
thetical spectrum. From the NRP’s molecular structure, a unique series of fragments are
created, based on fragmentations on their amide cleavage sites. These generated struc-
tural fragments are calculated estimations as how the protonated NRP may fragment in
the collision-induced dissociation (CID)[26, 27] within the gas phase of an MS/MS exper-
iment. To generate these fragments, iSNAP first loads the structure from its SMILES
code and labels all the linear, cyclic and cyclic-branching components. Each amide bond
is tagged as a potential site for cleavage. The hypothetical spectrum is compiled by ex-
haustively fragmenting the structure. The program enumerates every combination of two
amide bonds, which are previously tagged, within the structure. For each combination, it
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Figure 3.2: Mass distribution of the 1107 database NRPs.
breaks the structure at the two bonds, and collects the fragments. This process yields a
set of generated structural fragments. As an example, Figure 3.3 shows the SMILES code
of bacitracin-A and samples of generated structural fragments.
From the 1107 NRP structures, a library of 1107 hypothetical spectra was created with
the above process. In a hypothetical spectrum, mass-to-charge ratios (m/z) are calculated
using the fragments resulted from amide cleavages described above, assuming the precursor
ion is singly charged. To generate the m/z values, mass offsets of +H and +H+1 are
added for each fragment to account for protonation and the first isotope ion, respectively.
Additional m/z values are added as well with further consideration of common neutral
losses (water, ammonium and carbon monoxide).
The m/z values in constructing a hypothetical spectrum represents where a fragment
ion is likely to be observed in a real singly-protonated MS/MS spectrum of the NRP.
Thus, when the hypothetical and experimental spectra of the same NRP are compared, a
significant number of high-intensity peaks should be shared by both spectra. However, if
the two compared spectra are unrelated, while random matching can still produce some
shared peaks, the number and intensities of the shared peaks is usually much less. Thus, by
examining the shared peaks, information can be obtained about whether the experimental
spectrum is from one of the known NRPs in the database. A hypothetical spectrum con-
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Bacitracin-A 
Figure 3.3: SMILES code and sample theoretical fragments of bacitracin-A.
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tains multiple diagnostic fragments for the NRP and allows for the efficient dereplication.
Input MS/MS data files, containing experimental spectra, can be searched and compared
to the hypothetical spectra of database NRPs in order to determine the significance of the
matched fragment peaks.
Compared to the calculation of hypothetical spectra for linear peptides in traditional
database search algorithms, the calculation for NRPs is time consuming. It involves the
parsing of SMILES code, tagging chemical components in graphs, and then sub-graphs
can be generated as fragments. The runtime would be not acceptable if performing the
calculation on-the-fly, as it was done traditionally. However, hypothetical spectra are
static information which stay fixed each time a search is launched. Therefore, we move the
calculation for database NRPs off-line, as a pre-computation. The generated hypothetical
spectra are stored with the NRP database, each linked to the corresponding SMILES entry.
In this way, it vastly speeds up the search algorithm, as only the hypothetical spectra of
user-uploaded NRPs, instead of the whole NRP database, need to be calculated in a search.
3.3 Scoring Scheme
Having introduced how hypothetical spectral can be computational generated from
compounds in the NRP database, the next step is to design a scoring scheme that serves
two purposes. First, given the MS/MS spectrum of an analyte, the scoring scheme is used to
retrieve the highest-scoring hypothetical spectrum. Assuming the analyte’s structure is in
the library, it should be the one that was used to compute the highest-scoring hypothetical
spectrum. Secondly, the scoring scheme should help judge whether the assumption that
the analyte is in the library is true.
Three scores are computed for these two purposes: (1) raw score, (2) P1 score, and (3)
P2 score. Raw score measures the matching quality between an MS/MS spectrum and a
hypothetical spectrum. It is used by the algorithm to rank the compounds in the database
for a given spectrum. However, the absolute value of the raw score is not an interpretable
measurement to judge whether the match is real or purely random. The P1 and P2 scores
are designed to serve these purposes. Both P1 score and P2 score indicate the significance




The raw score represents the basic spectrum-matching score, indicative of how well
an MS/MS spectrum is matched with a hypothetic spectrum that is generated from a
linear SMILES string. To calculate a raw score for a match, the algorithm first loads the
singly charged or protonated hypothetical spectrum from the database. A simple noise
filtering step is performed on the input MS/MS spectrum in order to remove peaks with
low intensity values. Peaks with relative intensity less than 0.5% are removed, where the
relative intensity of a peak is the intensity ratio between the peak and the highest peak in
the spectrum. Such noise filtering is applied in order to reduce the possibility of randomly
matched peaks, and is a common practice in designing of peptide-spectrum matching score
in proteomics. The remaining peaks are then matched with the hypothetical spectrum.
As mentioned previously, hypothetical spectra are generated with the assumption that
the precursor ion is only charged with one proton. However, an input MS/MS spectrum
can be multiply charged. It is very common to see a precursor ion is doubly or triply
charged. In such case, the algorithm adjusts the singly charged hypothetical spectrum to
account for difference in charge states. The multiply charged ions are added by assuming
additional protons are attached to the structural fragments. When the parent ion of the
MS/MS spectrum has charge k, the m/z values of hypothetical fragments with charges up
to k are combined to form the charge-k hypothetical spectrum.
By using a mass error tolerance of 0.1Da, the algorithm finds all peaks in the input




log10(200 ∗ relative intensity of mi)
The factor 200 in the formula ensures that a peak with relative intensity 0.5% con-
tributes score 0. The mass error tolerance 0.1Da is set empirically to accommodate the
random and system errors arising from low resolution mass spectra. The mass tolerance
value is, in essence, due to the mass accuracy of the mass spectrometer. Values set to low
will limit the amount of matched fragments, while higher values will generate a greater
number of matches, possibly increasing the chance for random assignments.
For each MS/MS spectrum, the raw score is calculated against the database compounds
within a mass range of 0Da to [M ] + 100Da, where [M ] represents the MS/MS spectrum’s
precursor mass. Having a relaxed mass range ensures sufficient raw scores are calculated for
the reliable estimation of a statistical distribution, which is important for the calculation of
the P1 score as presented later. Meanwhile, the mass upper bound of [M ]+100Da avoids the
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potential bias arising from large molecular weight compounds, as more structural matches
could be made randomly for larger compounds. Only database compounds within the mass
range of [M ]± 1Da are subjected to P1, P2 calculation, and are considered as candidates
for that MS/MS spectrum.
3.3.2 P1 Score
A P1 score is introduced as a normalized version of the raw score in order to add a
statistical significance. To calculate the P1 score, the input MS/MS spectrum is scored
against the hypothetical spectra of all database NRPs within the 0Da to [M ]+100Da mass
range, the statistical distribution of the raw scores closely matches a gamma distribution.
The gamma distribution is selected empirically as it best fits the data. The parameters
required by the gamma distribution are estimated with the maximum-likelihood method,
and the estimated gamma distribution curve is plotted to the raw scores. (See Figure 3.4)
For each compound, the p-value is the exceedance frequency at the compound’s raw
score, which is the area under the curve and to the right of the Raw score. The p-value
represents the probability of that a random structure is scored higher with the MS/MS
spectrum than the current structure. A low p-value indicates the match is unlikely random
and therefore is likely a correct one. A P1 score is derived from the p-value, whereby, a
higher value represents a greater significance of being correctly matched.
P1 score = −10 log10(p-value)
3.3.3 P2 Score
Similarly to the P1 score, a P2 score is calculated for each candidate structure within
the mass range of [M ]± 1Da.
The P2 score measures the matching quality between an MS/MS spectrum and the
hypothetical spectrum of an NRP compound. Decoy spectra are generated by shifting the
original MS/MS spectrum. All the fragment peaks are offset by 1Da at a time, consecu-
tively up until the highest m/z value in the MS/MS spectrum. Once the offset peaks have
reached the highest m/z value, they are rotated back to the lowest m/z value, and further
rotated until they have reached their original m/z value. Each 1Da shift produces a new
























Figure 3.4: Calculation of P1 score on a bacitracin-A MS/MS spectrum.
score in the SEQUEST algorithm, which was the first computer algorithm for matching
ribosomal peptides in a database with the MS/MS spectral data.
The P2 score is calculated in a similar fashion to that of P1. However, the gamma
distribution of the raw scores is estimated from the raw scores between the decoy spectra
and the candidate structure. The p-value is the exceedance frequency at the original
MS/MS spectrum’s raw score. (See Figure 3.5)
The p-value represents the probability of that a random spectrum being scored higher
with the candidate structure than the original MS/MS spectrum. A low p-value indicates
a greater probability of the spectrum being correctly matched. A P2 score is derived from
the p-value, whereby, a higher value represents a greater significance of being correctly
matched.











0 5 10 15 20 25 30 35 40 45 50 55 60













Figure 3.5: Calculation of P2 score on a bacitracin-A MS/MS spectrum.
3.3.4 P1, P2 Thresholds and Result Filtering
iSNAP analyzes each input MS/MS spectrum individually, and the scoring scheme
is applied. As mentioned previously, NRPs within the mass range of [M ] ± 1Da are
considered as candidates for an input spectrum. If no NRP in the database is found within
the [M ]± 1Da mass range, then no candidate can be established. As such, there would no
identification for with that MS/MS spectrum. For an MS/MS spectrum with candidates,
a P1 score and a P2 score is generated for each candidate.
iSNAP applies thresholds on P1 and P2 scores to judge whether a candidate is signif-
icant enough to be reported. The threshold values are determined by threshold training
experiments, which are explained in Experiment II. A candidate compound is regarded as
identified only if it has both P1 and P2 scores above the corresponding thresholds and also
have the highest P1 score among all the candidates for that spectrum.
To ensure the input MS/MS is well matched to the compound, additional filtering is
applied to the candidates above thresholds. A candidates is discarded if its hypothetical
spectrum matches the input spectrum with less than 5 peaks. On top of that, a candidate
is also discarded if number of the matched peaks are less than 10 while more than 75% of
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matched peaks have relative intensity less than 2%.
In the output, iSNAP assembles identification report for each MS/MS spectrum; outlin-
ing the scan number, retention time (if applicable), precursor m/z, charge state, precursor’s
mass, as well as information about all the candidates for the spectrum, including the can-
didate’s name, SMILES code, monoisotopic mass, the number of fragments matched, raw
score, P1 score and P2 score. Figure A.2 is the screenshot of a typical identification report.
3.4 Experiments and Results
3.4.1 Experiments Overview
In this section, we present five experiments on iSNAP database search. The first two
experiments were designed to support the development of iSNAP, and the following three
aimed to evaluate iSNAP’s performance with progressively challenging settings.
Experiment I checked the scoring scheme’s capability in ranking the NRP candidates
for a single MS/MS spectrum. In order to make a correct identification, it is essential
for the scoring scheme to distinguish the genuine candidate from all structures in the
database. This experiment tested iSNAP’s scoring scheme with the MS/MS spectra of
bacitracin-A. Each bacitracin spectrum was scored with all NRPs in the database. With
the distribution of P1 and P2 scores over all database NRPs, we examined whether the true
structure bacitracin-A could be scored distinguishably higher than other NRPs.
Experiment II aimed to establish appropriate thresholds for P1 and P2 scores. The
thresholds are used to determine whether a top candidate on the spectrum is significant
enough to be reported as an identification. The top candidate is the candidate NRP with
highest P1 score, which is considered the best match for the spectrum. However, it does not
necessarily imply the match is true, because the true structure may not exist in the NRP
database. If the top candidate’s P1 or P2 score is low, it is more likely the top candidate
turns out to be a false match. It is important to set common criteria in order to interpret
the P1 and P2 scores across all the MS/MS spectra.
Furthermore, we demonstrate the effectiveness of iSNAP database search with progres-
sively challenging experiments. In Experiment III, iSNAP was evaluated to identify spiked
NRPs within complex mixtures. A mixture of six standard NRPs were spiked into 11
different fermentation media. LC-MS/MS data of each medium was acquired using data
dependent acquisition. iSNAP was used to detect the spiked NRPs from the 11 LC-MS/MS
dataset. As the fermentation media contained varying amounts of peptides and proteins
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but no NRP structures, it provided an ideal matrix in which to test the false positive and
false discovery rates.
Experiment IV and V were set up to demonstrate that iSNAP could detect naturally
produced NRPs. The experiments were designed to emulate how the software would be
used by lab researchers. In Experiment IV, the bacteria kutzneria sp.744 [39] was cultured
in regular medium to produce kutzneride. Kutzneride is a highly modified nonproteon-
genic nonribosomal peptide with complex structure. The LC-MS/MS of the extract was
analyzed by iSNAP to show the compound can be correctly identified. Moreover, cultured
in brominated medium, kutzneria sp.744 was anticipated to produce di-bromo-kutzneride,
which was not in the NRP database, but the structure could be predicted. By including
the brominated structure, di-bromo-kutzneride, into the NRP database, iSNAP identified
it from the MS/MS spectra and helped confirm its existence. In Experiment V, Bacillus
sp.[16] was cultured to produce tyrocidines, which is a series of bioactive cyclic NRPs with
closely similar structures. iSNAP was used to interrogate the LC-MS/MS of the microbial
culture, and distinguishably identified a series of compounds in tyrocidine family.
The mass spectral data used in this research were generated by research collaborators
in Nathan Magarvey lab in McMaster University, using a Bruker amaZon-X ion-trap in-
strument with electro-spray ionization source. The mass spectrometer was coupled to a
Dionex Ultimate 3000 HPLC system to perform LC-MS/MS analysis.
3.4.2 Experiment I - Validation of P1 and P2 Scoring
The experiment aimed to validate that the scoring scheme is capable of distinguishing
the true candidate from 1107 database NRPs for an input MS/MS spectrum. To evaluate
the scoring scheme, an MS/MS spectrum of doubly protonated (711.82 m/z) bacitracin-A
was selected as the input. The spectrum was searched with the database, and P1 And P2
scores were calculated for each database NRP. As the true candidate bacitracin-A is in the
database, it was expected that bactracin-A would have a distinctively higher P1 and P2
score than those of other database NRPs.
We sorted the 1107 database NRPs by their P1 scores. Table 3.1 shows the top five
NRPs for the bacitracin-A spectrum. It is noticed that the true candidate bacitracin-A was
scored distinguishably higher in both P1 and P2, which are 57.6, 72.3, respectively. The
second ranked NRP, bacitracin-F, is also in the bacitracin family with a similar structure
to bacitracin-A, as shown in Figure 3.6. It was scored with P1=29.8, P2=31.7, which was
higher than the others but substantially lower the scores of the true candidate. The result
30
Rank Database NRP Mass Raw score P1 score P2 score 
1 Bacitracin_A 1421.748 59.09543 57.5842 72.31199 
2 Bacitracin_F 1418.701 30.48299 29.84443 31.7187 
3 Tyrocidine-D 1370.692 24.79772 24.32377 18.72659 
4 Tridecaptin_B_gamma 1459.803 22.1822 21.78215 18.56334 
5 Petriellin_A 1430.878 22.10258 21.70476 31.00149 
Table 3.1: P1, P2 scores of the top five database NRPs for a bacitracin-A MS/MS spectrum.
The bacitracin-A MS/MS spectrum is searched with the database of 1107 NRPs. The true
candidate bacitracin-A is scored at the top, distinguishably higher in both P1 and P2 score.
The second ranked NRP, bacitracin-F, has the similar structure to bacitracin-A. It is scored
higher than the others but substantially lower than bacitracin-A.
illustrates that the scoring scheme is usable in distinguishing the true candidate from the
database, even from NRPs with similar structures.
To further demonstrate this point, a working standard of bacitracin-A was infused
directly into the mass spectrometer for approximately 1min. This MS/MS experiment
generated 56 bacitracin-A scans. The test was repeated on each of those scans. For each
scan, the P1 and P2 scores of the true candidate, bacitracin-A, was recorded, represented
by a blue point in Figure 3.7. The scores of other database NRPs are represented by red
points. As such, the results on 56 bacitracin-A scans are overlaid in Figure 3.7, which
shows bacitracin-A is consistently scored higher, compared to other database structures.
3.4.3 Experiment II - Determination of P1 and P2 Score Thresh-
olds
This experiment aimed to determine the values of P1 and P2 thresholds. iSNAP uses
the thresholds as criteria by which it decides whether to report an MS/MS spectrum’s top
candidate as an identification. When an MS/MS spectrum truly corresponds to a database
NRP, the P1 and P2 scores should be high, as shown in the previous experiment. However,
an MS/MS spectrum of other substance outside the database can still have candidates




Figure 3.6: Structural comparison of bacitracin-A and bacitracin-F. The two structures




































Multi-scan Score Distribution plot: P1 vs P2 
Figure 3.7: Score distribution of the 1107 database NRPs on 56 bacitracin-A MS/MS
spectra. The P1 and P2 scores of the true candidate, bacitracin-A, are represented by a
blue points. The scores of other database NRPs are represented by red points. The true
candidate bacitracin-A is consistently scored higher in both P1 and P2.
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candidates cannot match well with the input spectrum. Therefore, even the top candidate
should have low scores.
Higher P1 and P2 scores generally imply a greater probability for the top candidate to
be true. Ideally, appropriate thresholds is supposed to optimally separate the true and
false top candidates. To establish appropriate thresholds, it is necessary to know the P1
and P2 distributions of the true and the false.
The scores of true top candidates were generated using the MS/MS spectra of six
different NRPs. The six NRPs are in the database, including bacitracin-A, cyclosporin-A,
gramicidin-A, polymyxin-B, surfactin and seglitide. They represent typical NRP structures
(See Table 3.2). For each NRP, a set of MS/MS spectra were generated by infusing the
NRP working standard to the mass spectrometer. A total of 367 MS/MS spectra were
generated from the six compounds. iSNAP searched these spectra with the NRP database.
All spectra had the correct NRP scored as the top candidate. The P1 and P2 scores of
these true top candidates were acquired, and used as positive controls in Figure 3.8. In
Table 3.2, the structures of the six NRPs are illustrated and the highest P1 and P2 scores
for each compound are listed.
The scores of false top candidates were generated with the LC-MS/MS data of 11
common fermentation media. The 11 media are blank controls with no NRPs existed.
A total of 12569 MS/MS spectra were acquired by data dependent acquisition. Their
precursor mass distributed over a range from 300 to 2700 m/z. Processed with iSNAP
database search, 6744 out of 12569 MS/MS spectra had least one candidate from the NRP
database. As no NRPs existed within those media, the top candidate must be falsely
matched to the spectrum. Their P1 and P2 scores were generally low, and are used as the
negative controls in Figure 3.8.
The score distribution of the true and false top candidates are shown in a P1-P2 scatter
plot (Figure 3.8). We empirically estimated the P1 threshold at 27, corresponding to a
p-value at 0.002, and the P2 threshold at 24, corresponding to a p-value at 0.004. The
thresholds balanced the sensitivity and specificity at 91.5%, 99.8%, respectively. It allowed
a sufficient amount of true candidates to be reported, while kept a low ratio of false
positives. Using the estimated thresholds, 335 of 367 true top candidates could be positively








Candidate Precursor Charge state Precursor
m/z mass





















1881.5 1881.1 34.6 40.7
1421.7 1421.7 57.6 72.3
1202.0 1202.7 34.6 35.0
1036.2 1035.7 28.5 31.2
1202.4 1201.8 35.1 41.8
809.0 808.4 57.5 48.2
 









































































































































































































Figure 3.8: P1-P2 distribution of true and false top candidates for threshold determination.
The scores of true candidates were generated with MS/MS spectra of six standard NRPS.
The scores of false candidates were generated with 11 different media panel. Thresholds
on P1 and P2 are empirically determined at 27 and 24, respectively.
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3.4.4 Experiment III - Identification of Six Spiked NRPs within
Complex Fermentation Media
In this experiment, the determined P1 and P2 thresholds were examined in the analysis
of LC-MS/MS datasets from complex mixtures, in order to check their ability in separating
the true and false top candidates. The thresholds are used as criteria for deciding whether a
top candidate should be reported as an identification. It is important to have an estimation
about false discovery rate [40] and false positive rate when the determined P1, P2 thresholds
are applied, in the analysis of complex samples.
The thresholds were evaluated with spike-in studies of 11 fermentation media, each
spiked with the mixture of six NRPs. For each spiked NRP, the final concentration was set
to 50µg/mL. The panel of 11 spiked fermentation media was analyzed with LC-MS/MS,
where tandem spectra were generated using data dependent MS/MS acquisition.
Automated MS/MS acquisition generated a total number of 6793 MS/MS spectra from
the 11 fermentation media. The algorithm analyzes these MS/MS spectra with our scoring
scheme. It turned out 4198 out the 6793 MS/MS spectra has at least one candidate
with a ±1Da precursor mass window. For the 4198 scans with candidates, the algorithm
matches the candidate with highest P1 score to the spectrum. We call such a match as a
PSM (peptide-spectrum match). A PSM is true if the top scored candidate is the genuine
structure for the spectrum, otherwise the PSM is false. In this sense, the 4198 scans with
candidates yielded 4198 PSMs, each with a P1 score and a P2 score. We ignored the rest
of 2595 scans with no candidate, as they must correspond to compounds outside the NRP
database. The database search algorithm can not make identifications if the compound is
not in the search scope.
To estimate the false discovery rate and the false positive rate, we let the null hypothesis
be a false PSM having both P1 score and P2 score above the thresholds, which is the
case that an MS/MS spectrum is wrongly matched to a database NRP but the algorithm
considers it as significant and report it as an identification. We perform multiple hypothesis
tests on PSMs by running this experiment.
In Figure 3.9, the 4198 PSMs are plotted on P1 and P2 scores. Further analysis showed
that 1455 of the 4198 PSMs were matches to one of the six spiked NRPs. Those PSMs are
marked accordingly. PSMs not matched to any one of the spiked NRPs are marked with
red dots.
To validate whether the 1455 PSMs were true, we inspected how well these MS/MS
spectra were matched. For each spiked NRP, its MS/MS spectra at the same charge state



























Figure 3.9: P1-P2 distribution of 4198 PSMs in the analysis of 11 NRP-spiked fermentation
media. Each point in the figure indicates a PSM (peptide-spectrum match), which is the
match of an MS/MS spectrum and its top scored candidate. 1455 of the 4198 PSMs are
true PSMs to one of the six spiked NRPs. The other 2743 PSMs are false, marked as red
dots. The majority of PSMs to the six spiked NRPs scored above the P1 P2 thresholds
except matches to polymyxin-B.
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were the same. A match was considered to be true if the MS/MS spectrum conformed
with common fragmentation pattern of the matched NRP. The 1455 PSMs were manually
examined, and all of them were deemed to be true.
The rest of 2743 PSMs not matched to spiked NRPs were determined to be false.
Theoretically, these PSMs could be categorized to two cases. In the first case, the MS/MS
spectrum was indeed a genuine scan of a spike NRP, but the algorithm wrongly ranked
another NRP to be the highest scored candidate. In the second case, the spectra could
correspond to other substances in the medium. However, it has been known that there are
no NRPs in the medium, therefore, any candidate from the NRP database matched to the
spectrum must be false. In conclusion, the rest of 2743 PSMs were all false.
At this moment, the distinguishing power of P1 and P2 thresholds could be evaluated.
The P1 and P2 thresholds had been previously established as 27 and 24, respectively, and
was applied to the 4198 PSMs in Figure 3.9. For clarity, we define an identification as a
PSM with P1 and P2 above thresholds.
We checked the false discovery rate and false positive rate with the thresholds. In
this case, false discovery rate is the number of false identifications over all identifications.
These were 23 false PSMs above both the thresholds, which were the false identifications.
Meanwhile, 992 of the 1455 true PSMs were identified. This yielded a false discovery rate
of 23
23+992
= 2.27%. False positive rate is the number of false identifications over all false
PSMs, which was calculated as 23
2743
= 0.84%.
Table 3.3 shows the false discovery rate and false positive rate calculated separately on
each of the 11 datasets.
There is another indicator, true positive rate, which is calculated as the number of true
identifications over all true PSMs. A higher true positive rate suggest less true PSMs will
be missed in the identification report. This is thought less important with the reason that
dereplication can be made as long as one of true PSMs has the NRP scored above the
thresholds.
As for the identification of the six spiked NRPs, the majority of PSMs to the six spiked
NRPs could be identified from the 11 fermentation media except polymixin-B. In TSB and
LB media only 4 out of the six spiked NRPs could be identified, while 5 out of the six
were identified in YPD, YMG, GYM, Pharmamedia, Grasseed, Fishmeal and in CY. In
the case of polymixin-B, earlier MS/MS infusion data generated P1 and P2 scores above
the thresholds. However, it was not dereplicated in most media under automated data
dependent acquisition. We speculate this is due to matrix effects in which the coextracted



















1 YPD 774 467 75 48 392 1 2.04% 0.26% 
2 YMG 663 403 87 67 316 0 0.00% 0.00% 
3 GYM 440 259 130 94 129 3 3.09% 2.33% 
4 TSB 699 402 67 61 335 3 4.69% 0.90% 
5 LB 736 443 88 61 355 4 6.15% 1.13% 
6 Nutrient 709 493 200 86 293 3 3.37% 1.02% 




603 466 145 118 321 0 0.00% 0.00% 
9 Fishmeal 496 296 205 152 91 2 1.30% 2.20% 
10 R2A 518 312 192 126 120 1 0.79% 0.83% 
11 CY 732 426 126 73 300 4 5.19% 1.33% 
Summary 6793 4198 1455 992 2743 23 2.27% 0.84% 
Table 3.3: Detailed result on 11 spiked fermentation media with false positive rate and
false discovery rate calculated.
The experiment demonstrated that the determined thresholds are capable of separating
the true and false top candidates, with the highest false positive rate less than 3% and
false discovery rate less than 7% across 11 media. This indicates iSNAP algorithm has
the capable of dereplicating a mixture of NRP compounds from complex matrices. The
processing speed for the 11 LC-MS/MS datasets is approximately 15 MS/MS scans per
second. This makes iSNAP a practical tool for automated high throughput dereplication
of NRP compound in complex mixtures.
3.4.5 Experiment IV - Identification of Kutzneride and Di-bromo-
kutzneride
In this experiment, iSNAP was challenged with naturally produced NRPs within crude
extract. The experiment emulated a lab research in which the bacteria kutzneria sp.744 [39]
was cultured to produce an antibiotic NRP kutzneride. Kutzneride is a cyclic nonribosomal
peptide bearing a high degree of non-proteinogenic amino acids. iSNAP was utilized as
a software tool to analyze the LC-MS/MS acquisitions from the fermentation extract and
to confirm the existence of kutzneride. It is difficult to the detect naturally produced
kutzneride as the compound is produced in low abundance[41]. Moreover, by brominating
the regular medium, we aimed to produce a novel analog to kutzneride with kutzneria
















































Figure 3.10: Molecular structures of kutzneride and di-bromo-kutzneride.
biosynthesis of kutzneride, it is expected to produce di-bromo-kutzneride. The compound
is a close analog to kutzneride by replacing the two chloride groups with bromine groups.
Figure 3.10 shows the molecular structures of kutzneride and di-bromo-kutzneride. iSNAP
is used to verify the assumption by checking the existence of di-bromo-kutzneride with
MS/MS.
The bacteria was cultured by our research collaborators in Nathan Magarvey lab at
McMaster University. In the experiment, kutzneria sp.744 was first grown on ISP-2 agar
plates for 7 days prior to a 14-day culturing in Melin Norkrans medium. Culture super-
natants were extracted with a HP-20 resins, and subjected to chemical solvent partitioning.
The 100% organic fractions where collected and subjected to LC-MS/MS analysis.
LC-MS/MS data files were processed by iSNAP. Kutzneride is in the database of 1107
NRPs. It was identified by the software from the crude organic extract with 4 main
fragment peaks (837.29, 836.29, 743.23 and 609.20m/z) being matched with the theoretical
spectrum, resulting in highest P1 and P2 scores of 31.3 and 33.4 respectively. This initial
test was done to reveal that iSNAP could dereplicate kutzneride, but also importantly did
not result in any false positives identified in the extract.
A second test was conducted to determine if the iSNAP algorithm could be used to
confirm the production of di-bromo-kutzneride in brominated medium. To obtain the novel
analog of kutzneride, Melin Norkrans medium is modified using a series of bromide salts. As
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Figure 3.11: Ion counts in the mass window of kutzneride and di-bromo-kutzneride over LC
retention time. The bottom chart is acquired with LC-MS on the fermentation using regular
medium, implied kutzneride was possibly produced and indicated di-bromo-kutzneride can
not be produced in the regular medium. The top chart is acquired with LC-MS on the
fermentation using brominated medium. With a substantial increase of ion count in the
mass window of di-bromo-kutzneride, it was highly possible the brominated compound
was produced. iSNAP was used to structurally confirm the existence of kutzneride and
di-bromo-kutzneride, respectively, with MS/MS spectra.
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the mass of di-bromo-kutzneride was easily calculated, we checked the mass on the LC-MS
chromatogram of the resulting extract. The chromatogram implied the possible presence
of di-bromo-kutzneride with a molecular weight of 942.1 [M + H]+ and a decrease in the
production of kutzneride (See Figure 3.11 Top). A series of MS/MS scans were acquired
using the calculated mass as the manually selected acquisition window. iSNAP analyzed
the MS/MS dataset with the database of 1107 NRPs and reported no identification, as di-
bromo-kutzneride was not in the NRP database, we constructed the molecular structure in
ChemDraw, and exported the SMILES code. After adding the SMILES code of di-bromo-
kutzneride to the database, iSNAP was used to re-analyze the MS/MS data. A total of
4 high intensity fragment peaks where matched form the MS/MS spectra (942.18, 925.18,
924.18 and 830.12 m/z). The highest P1 and P2 scores on the MS/MS spectra were 75.9 and
29.3 respectively. The matched peaks represented the fragments of di-bromo-kutzneride,
which confirmed that a correct identification was made.
3.4.6 Experiment V - Identification of a Series of NRPs in Ty-
rocidine Family
In this experiment, iSNAP is tested to identify a series of naturally produced NRPs
with similar structures. It is mention previously that NRPs in a same family can be
produced simultaneously in a biosynthesis pathway, resulting structurally similar NRPs in
the same microbial fermentation. As an example, tyrocidine family contains more than 28
antibacterial cyclic NRPs[16], and they only different at a few amino acid residues (Figure
1.4). Out of the 28 known tyrocindines, only five of them, tyrocidine A, B, C, D and E, have
been conclusively characterized, and have the SMILES code in our NRP database. This
phenomenon not only gives a good reason to develop an NRP analog search algorithm, but
also provides a decent challenge for iSNAP database search. In order to be a practical tool
for NRP dereplication, iSNAP should be able to simultaneously and distinctively identify
those similar NRPs in the same LC-MS/MS dataset.
In Nathan Magarvey lab at McMaster University, bacitracin strain Bacillus sp.[16] was
cultured to produce tyrocidines. In the course of screening the microbial culture for the
antibacterial compounds, an assay was used to detect antibiotic agents from crude fermen-
tation extracts. The crude extract was separated by HPLC (Figure 3.12), fragmented a
96 well plate for antibacterial testing, and a bioluminescent strain of staphylococcus was
used as a bioactivity indicator. Figure 3.13 shows the screening result of the 96 well plates.
Bioactivity was revealed in well C11, D1-6, D8, E1 and F2. The high number of actives
from this crude extract made it a suitable material to test iSNAP database search for NRP
dereplication.
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Figure 3.12: Liquid chromatogram of the Bacillus sp. extract. The bioactive fractions D1-
D6 corresponds to the retention time of 36 - 42min. The LC chart shows the fermentation
is a complex mixture with various compounds.
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Figure 3.13: Bioactivity screening of LC fractions of Bacillus sp. extract. A bioluminescent
strain of staphylococcus was used as the bioactivity indicator. Grey wells (C11, D1-6, D8,
E1 and F2) indicates that the fractions are antibacterial and have killed the staphylococcus.
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Fraction # Rt ID Candidate P1 P2
(96-well) (min) Mass score score
D1,E1 40.5 Tyrocidine A 1269.7 84.7 44.3
D2-D5 38.6 Tyrocidine B 1308.7 86.8 61.6
D2-D6 37.0 Tyrocidine C 1347.7 85.1 44.3
D2-D5 39.0 Tyrocidine D 1370.7 69.5 41.5
D1,E1 40.8 Tyrocidine E 1253.7 72.8 55.0
* Highest P1 result reported
*
Table 3.4: Identification report of LC-MS/MS of the Bacillus sp. extract.
iSNAP was used to interrogate the LC-MS/MS of the microbial culture with the hope
to find the tyrocidine A, B, C and D, which are normally the most abundant in the tyro-
cidine mixtures. 2455 MS/MS spectra were automatically acquired with data dependent
acquisition from LC-MS, and were analyzed by iSNAP with the NRP database. As the
result, iSNAP not only identified tyrocidine A, B, C, D but also a lesser compound tyro-
cidine E. Table 3.4 shows the identification report for the five compounds. All of them
had P1 and P2 scores that were significantly greater than the empirical threshold values of
P1=27, P2=24.
The LC-MS was reviewed to further validate the identifications of tyrocidine A, B, C, D
and E. The LC-MS chromatogram was filtered by the calculated precursor mass from these
structures, showing the ion counts of the five tyrocidines (Figure 3.14). The five compounds
eluted from 36-42min, with slight differences in retention time, which suggested the eluted
compounds probably had similar structures and were in the same family. The observation
was consistent with the assumption that tyrocidine A, B, C, D and E existed in the sample.
In this iSNAP analysis, 45 of 2455 MS/MS scans had the top candidate scored over
the thresholds, of which 41 belong to the tyrocidine family. The remaining 4 hits were
considered false identifications, but all have low P1 and P2 scores. The 4 false hits ranked
41-43, 45 after sorting the 45 identifications by P1 score, and all 40 identifications before
it are tyrocidines. In addition, it was noticeable that tyrocidine E was positively identified
from the NRP database and dereplicated with high confidence (P1=72.8 and P2=55.0),
even though its relative abundance was 2-3% to the most abundant tyrocidine B, showing
that low abundant NRP could still be dereplicated with iSNAP.
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Figure 3.14: Ion counts in the mass window of tyrocidine A, B, C, D, E over LC retention
time. The five compounds eluted from 36min-42min, with slight differences in retention
time, which suggested they probably had similar structures and were in the same family.
The observation was consistent with the assumption that tyrocidine A, B, C, D and E




Nonribosomal Peptide Analog Search
4.1 Overview
In the previous chapter, we introduced iSNAP as an informatic tool that identifies
nonribosomal peptides from tandem mass spectra. It is tested to be an effective tool and
can facilitate NRP dereplication in lab research. However, the database search algorithm
has its own limitation that only the NRPs in database can be identified. It is common that
NRPs with similar structures co-exist with the identified NRPs. We refer these similar
NRPs, which are not in the database, as analogs. In some cases, those analogs need to
be dereplicated as well, because they may not be the interesting subjects in a research.
On the other hand, if a research aims to find novel analogs in an NRP family, it can be
exciting not only to detect but also acquire some structural information of analogs with the
LC-MS/MS of crude extract. Nonetheless, in both cases, a search program for identifying
analogs is useful.
To meet the needs, we expanded the database algorithm to be capable of identifying
NRP analogs. iSNAP analog search is designed as a procedure which follows iSNAP
database search. It utilized the precisely identified NRPs in database search as “seeds” to
narrow down the search scope. MS/MS spectra in the input are re-analyzed to identify
analogs that are different at one building block to a seed NRP. Identified analogs are
reported with P1, P2 scores, as well as the database NRP from which the analog is derived,
along with the location of the different building block.
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It is known that most of successful database search algorithms for traditional peptides
have been extended to modified peptides [42] [43]. They let the user specify a small list
of possible modifications and also the amino acid residues where each modification can
be applied. A different approach is used for iSNAP analog search. We directly consider
the mass difference, between the scan’s precursor and a “seed”, as the mass of a possible
modification which can convert the “seed” to an NRP analog in the sample. We reason
that it is hard to have a selected list of anticipated modifications for NRPs, due to the
huge number of modifications that can occur. Our approach is more usable for NRP analog
identification, but it is limited to find analogs with only one different residue.
iSNAP analog search can be used iteratively. If some analogs are found using analog
search, these identified analogs can be used as “seeds” in the next round of analog search.
Therefore, it is possible to find analogs which are different at more than one building
blocks.
4.2 Method
The workflow of analog search is illustrated in Figure 4.1. To begin with, the analog
search algorithm obtains the list of identified NRPs from database search. As mentioned in
the previous chapter, those identified NRPs are the top candidates on their corresponding
MS/MS spectrum with P1 and P2 scores above the thresholds. The software allows users
to filter the list so that only the confidently identified NRPs are used as seeds. We denote
the seeds as Si, i = 1 . . . n. For each seed Si, the algorithm annotates amide bonds in
the structure, so that the monomer building blocks between two adjacent amide bonds are
detected. We denote these building blocks of Si as Rij, j = 1 . . .m. These building blocks
are the potential sites that can be altered to generate analog candidates.
In the process of analog search, the input MS/MS spectra are re-analyzed. For each
MS/MS spectrum, the precursor mass m is compared with the mass of each seed NRP,
m(Si), i = 1 . . . n. When the mass difference |m−m(Si)| is smaller than a user-specified ∆,
which is 150Da by default, iSNAP considers that the MS/MS spectrum could potentially
represent an analog to the seed NRP.
Analog candidates for the MS/MS spectrum are generated using Si with |m−m(Si)| <
∆. For each seed Si, its building block Rij are enumerated. By assuming the mass difference
m−m(Si) is caused by the structural change in Rij, iSNAP adds the mass difference to Rij,
so that the whole structure can then have same mass as the MS precursor. The structure
with an altered building block becomes an analog candidate for the MS/MS spectrum.
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Filtered input MS/MS 
spectra 
Analog Identification Report 
For each MS2 spectrum 
Filter seeds with precursor mass 
Generate analog candidates by applying 
mass difference to seeds 
Make analog identifications by applying 
P1 P2 thresholds 
Calculate P1  P2 for each candidate 
Iterative search 
NRP Identification Report 
iSNAP database  search 
iSNAP   analog    search 
Users select confidently  
identified NRPs as seeds 
Figure 4.1: Workflow of iSNAP analog search.
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The only exception is when m−m(Si) is negative and m(Rij) is too small to account for
the mass deduction. With this method, a pool of analog candidates can be generated.
Using the same scoring scheme in database search, P1 and P2 scores are calculated for
each analog candidate. In the first step, the analog candidate’s hypothetical spectrum is
generated with in-silico fragmentation. iSNAP matches the hypothetical spectrum with
the input MS/MS spectrum to calculate a raw score. The raw score is then converted to P1
score using the raw score distribution which was previously estimated in database search
by scoring the input MS/MS spectrum with the hypothetical spectra of database NRPs.
To calculate a P2 score, decoy spectra generated by shifting the input MS/MS spectrum
are compared to the hypothetical spectrum of the analog candidate. This generates a raw
score distribution, and it is used to convert the original raw score of to a P2 score.
Finally, an analog candidate is reported as identified if the following criteria are met.
1. The candidate should have the highest P1 score among all candidates generated for
the MS/MS spectum.
2. The candidate should have both P1 and P2 scores above the corresponding threshold.
3. The number and quality of matched peaks in MS/MS spectrum should pass the
additional filtering described in Section 3.3.4.
In the report, iSNAP outputs the SMILES code of the seed NRP and marks the building
block where the mass difference is located.
4.3 Experiments and Results
4.3.1 Experiment VI - Iterative Analog Search for Naturally Pro-
duced Tyrocidines
The purpose of this experiment is to evaluate the usefulness of iSNAP analog search
in identifying NRP analogs within crude fermentation extract. iSNAP analog search was
performed on the LC-MS/MS data previously examined in Experiment V. The LC-MS/MS
data was acquired from crude extract of Bacillus sp. fermentation and contains various
compounds in the tyrocidine family. With database search, all five tyrocidines in the
database, tyrocidine A, B, C, D and E were identified. We argue that tyrocines are excellent
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testing material for this analog search algorithm, as it is common that compounds in
tyrocidine family are only different at one amino acid residue from each other.
Figure 4.2 compares the molecular structures of tyrocidine A, B, C, D and E. It is
noticed that,
• Tyrocidine-A (1269.7Da) → Tyrocidine-E (1253.7Da)
by replacing the tyrosine residue at 7 with a phenylalanine residue (−16Da).
Tyrocidine-A (1269.7Da) → Tyrocidine-B (1308.7Da)
by replacing the phenylalanine residue at 3 with a tryptophan residue (+39Da).
• Tyrocidine-B (1308.7Da) → Tyrocidine-C(1347.7Da)
by replacing the D-phenylalanine residue at 4 with a D-tryptophan residue (+39Da).
• Tyrocidine-C (1347.7Da) → Tyrocidine-D(1370.7Da)
by replacing the tyrosine residue at 7 with a tryptophan residue (+23Da).
In this experiment, tyrocidine B, C, D and E were removed from the NRP database,
leaving tyrocidine-A as the only tyrocidine. Therefore, B, C, D and E were considered
analogs to A as if their structures were unknown. Analog search was executed iteratively
after the initial database search, with the precursor mass window ∆ set to 50Da. If the
algorithm works as expected, it should identify B and E in the first round using A as the
seed. In the second round, by selecting B as the seed, C should be identified. If the first
two rounds of analog search were successful, the third round should identify D with C as
the seed. This progression is illustrated as arrows in Figure 4.2.
On top of that, as the LC-MS/MS data was previously examined in Experiment V, the
database search results can be used to verify analog identifications. We use the tyrocidine
identified in Experiment V as the reference result for an MS/MS scan. With analog search,
if a scan is identified as an analog to tyrocidine-A and the reported structure is exactly
the same as the reference, the analog identification would be concluded as correct. If the
reported analog has the same total mass as the reference but the mass difference is located
at a wrong site, the identification would be considered as mis-localized. We cannot judge
the analog identifications on scans which were not identified in Experiment V, as there
would be no reference in such case.
In the result, the initial database search identified tyrocidine-A from the LC-MS/MS



























































Figure 4.2: Structural comparison of tyrocidine A, B, C, D and E. Arrows in this figure
indicate tyrocidine structures that only differ at one residue. Using A as the initial seed,
analog search should identify B and E as analogs. If executed iteratively, analog search
should identify B, C and D from A.
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Result Mass P1 Score P2 Score 
1247 40.5 635.9 2 1269.8 Tyrocidine A 1269.65 92.8 43.3 
1243 40.4 635.9 2 1269.8 Tyrocidine A 1269.65 89.9 42.5 
1240 40.3 635.9 2 1269.8 Tyrocidine A 1269.65 89.9 66.8 
1252 40.6 635.9 2 1269.7 Tyrocidine A 1269.65 67.4 42.1 
1254 40.7 1271 1 1270 Tyrocidine A 1269.65 64.8 25.9 
1258 40.8 635.7 2 1269.5 Tyrocidine A 1269.65 51.4 45.4 
849 28.5 845.8 2 1689.7 Trichotoxin E 1689.02 32.5 33.6 
Table 4.1: Identification report of the initial database search.
tyrocidine-A and trichotoxin-E. Tyrocidine-A was confidently identified with P1=92.8,
P2=44.3. The P1 score was higher than tyrocidine-A’s P1 score 84.7 in the previous
database search experiment 3.4.6, because B, C, D, E were removed from the database.
When there were no similar structures in database, the spectral match to tyrocidine-A
became more significant. As for trichotoxin-E, we considered it as a false identification,
because the scores were relatively low and it was only identified with one MS/MS scan.
The first round of analog search was performed with tyrocidine-A selected as the only
seed. The identification report is shown in Table 4.2. In the table, MS/MS scans iden-
tified with analogs of approximately the same mass difference are grouped together, and
highlighted by color shading. This reveals two scan groups among the 10 scans with ana-
log identifications. The two groups, each consisting of 4 scans, account for the mass of
tyrocidine B and E respectively. We checked the result in Experiment V, these scans were
indeed identified as tyrocidine B and E previously. As such, iSNAP analog picked up the
correct mass difference and identified tyrocidine B and E from the LC-MS/MS data. It
successfully determined the location of the different building block on 3 out of 4 MS/MS
scans in each group, and mis-localized the site for two scans in total.
In the second round, tyrocidine-B (tyrocidine-A+39.09@3) on scan 1162 was selected
as the seed. The identification report is shown in Table 4.3. Among all identifications,
tyrocidine-C was found as an analog to tyrocidine-B on three MS/MS scans. The difference
site was localized correctly on scan 988 and 1137, and a wrong site was picked for scan
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Analog search result Comments 







Result Modification P1 Score P2 Score 
Reference result by 
database search 
Conclusion 
1270 41.1 1255 1 1254 Tyrocidine A_analog -15.62@7 30.4 59.2 Tyrocidine E correct 
1259 40.8 627.9 2 1253.8 Tyrocidine A_analog -15.86@7 29.8 37.7 Tyrocidine E correct 
1269 41.1 627.8 2 1253.7 Tyrocidine A_analog -15.98@6 44.9 31.4 Tyrocidine E mis-localized 
1262 40.9 627.8 2 1253.7 Tyrocidine A_analog -15.99@7 58.5 46.2 Tyrocidine E correct 
978 32.7 642.3 2 1282.7 Tyrocidine A_analog +13.03@4 32.7 34.1 No result unknown 
1264 41 647.5 2 1292.9 Tyrocidine A_analog +23.26@6 27.6 36.6 No result unknown 
1162 38.2 655.4 2 1308.7 Tyrocidine A_analog +39.09@3 47 36.6 Tyrocidine B correct 
1190 38.9 655.4 2 1308.8 Tyrocidine A_analog +39.15@9 27.3 38.8 Tyrocidine B mis-localized 
1172 38.5 655.5 2 1308.9 Tyrocidine A_analog +39.25@3 27.7 49.4 Tyrocidine B correct 
1177 38.6 655.5 2 1308.9 Tyrocidine A_analog +39.29@3 27.5 51.1 Tyrocidine B correct 
Table 4.2: Identification report of the first round of analog search using tyrocidine-A as
the seed.
985. We select the highest scored tyrocidine-C (tyrocidine A+39.0@4+39.09@3) as seed
for the third round (Table 4.4). Tyrocidine-D was identified on scan 1192, 1197 and 1202,
and the site is correctly localized on scan 1197.
In the tables, we mark an identification as “unknown” if the MS/MS scan was not
previously identified in Experiment V. Even though the analog identification is made with
high P1 and P2 scores, we cannot conclude whether it is true. Such an analog identification
can be one of other tyrocidines in the same family, or even for a novel analog. As stated
before, there are more than 28 tyrocidines in the family, and the majority of them have
mass around 1300Da [16]. To check these identifications, the general rule is to examine
the number of identified scans in the same mass group. An analog identification is more
likely to be true if more scans are identified as the same structure. Moreover, the mass
difference need to be structurally explainable at the site. Finally, it is always worthwhile
to manually check how well the spectrum is matched to the analog structure.
The experiments shows the iSNAP analog search has the basic capability in finding
analog structures within a complex fermentation. It can find analogs differ from a seed NRP
at one building block. However, iSNAP analog search is not fully automated. It requires
human expertises in selecting seeds from identified structures and also in interpreting the
search result. In this sense, iSNAP analog search is usable as an assistant tool for NRP
analog deprelication and novel analog discovery. It exposes the MS/MS scans for possible
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Analog search result Comments 







Result Modification P1 Score P2 Score 
Reference result by 
database search 
Conclusion 
950 31.7 649.3 2 1296.6 Tyrocidine A_analog -12.02@10,   +39.09@3 27.9 24.2 No result unknown 
1264 41 647.5 2 1292.9 Tyrocidine A_analog -15.75@6,   +39.09@3 27.2 35.9 No result unknown 
978 32.7 642.3 2 1282.7 Tyrocidine A_analog -25.98@10,   +39.09@3 38.3 38 No result unknown 
929 31 637.8 2 1273.6 Tyrocidine A_analog -35.07@10,   +39.09@3 41.5 31.1 No result unknown 
967 32.3 661.8 2 1321.5 Tyrocidine A_analog +12.86@7,   +39.09@3 43.7 24.4 No result unknown 
1157 38 662.5 2 1322.9 Tyrocidine A_analog +14.27@10,   +39.09@3 31.1 39.5 No result unknown 
1164 38.2 662.5 2 1322.9 Tyrocidine A_analog +14.27@9,   +39.09@3 30 35.5 No result unknown 
1154 38 662.5 2 1323 Tyrocidine A_analog +14.3@10,   +39.09@3 31 37.7 No result unknown 
1035 34.6 663.4 2 1324.7 Tyrocidine A_analog +16.06@10,   +39.09@3 33.5 33.9 No result unknown 
1109 36.7 664.3 2 1326.5 Tyrocidine A_analog +17.86@2,   +39.09@3 56.3 24.1 No result unknown 
1257 40.8 666.9 2 1331.7 Tyrocidine A_analog +23.02@10,   +39.09@3 41 36.8 No result unknown 
1253 40.7 666.9 2 1331.7 Tyrocidine A_analog +23.03@10,   +39.09@3 42.4 33.3 No result unknown 
1249 40.5 666.9 2 1331.7 Tyrocidine A_analog +23.07@10,   +39.09@3 37.3 29.7 No result unknown 
1244 40.4 666.9 2 1331.9 Tyrocidine A_analog +23.2@9,   +39.09@3 27.5 33.4 No result unknown 
1102 36.5 667.8 2 1333.6 Tyrocidine A_analog +24.89@8,   +39.09@3 53.1 24.4 No result unknown 
942 31.5 668.8 2 1335.7 Tyrocidine A_analog +26.99@10,   +39.09@3 40.4 31.2 No result unknown 
947 31.6 668.8 2 1335.7 Tyrocidine A_analog +27.0@10,   +39.09@3 32.7 29.4 No result unknown 
937 31.3 668.9 2 1335.7 Tyrocidine A_analog +27.08@10,   +39.09@3 28.9 28.9 No result unknown 
922 30.8 668.9 2 1335.8 Tyrocidine A_analog +27.09@7,   +39.09@3 27.7 32.2 No result unknown 
1089 36.2 671.7 2 1341.4 Tyrocidine A_analog +32.76@5,   +39.09@3 29.3 24.9 No result unknown 
1225 39.9 673.8 2 1345.7 Tyrocidine A_analog +37.0@10,   +39.09@3 36.1 28.4 No result unknown 
1230 40 673.9 2 1345.7 Tyrocidine A_analog +37.03@10,   +39.09@3 27.6 28.5 No result unknown 
1220 39.8 673.9 2 1345.7 Tyrocidine A_analog +37.05@10,   +39.09@3 45.2 41.9 No result unknown 
1250 40.6 673.9 2 1345.7 Tyrocidine A_analog +37.07@10,   +39.09@3 27.7 29.8 No result unknown 
1255 40.7 673.9 2 1345.7 Tyrocidine A_analog +37.07@8,   +39.09@3 30.4 36.3 No result unknown 
988 33 674.8 2 1347.7 Tyrocidine A_analog +39.0@4,   +39.09@3 32.1 29.6 Tyrocidine C correct 
985 32.9 674.9 2 1347.7 Tyrocidine A_analog +39.05@9,   +39.09@3 27.6 28.7 Tyrocidine C mis-localized 
1137 37.5 674.9 2 1347.9 Tyrocidine A_analog +39.22@4,   +39.09@3 28.4 33.6 Tyrocidine C correct 
Table 4.3: Identification report of the second round of analog search using tyrocidine-B
(A+39.25@3) as the seed.
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Analog search result Comments 







Result Modification P1 Score P2 Score 
Reference result by 
database search 
Conclusion 
947 31.6 668.8 2 1335.7 Tyrocidine A_analog -12.01@10,   +39.0@4,   +39.09@3 35.5 31 No result unknown 
942 31.5 668.8 2 1335.7 Tyrocidine A_analog -12.02@10,   +39.0@4,   +39.09@3 41.4 31.3 No result unknown 
952 31.8 668.8 2 1335.6 Tyrocidine A_analog -12.11@7,   +39.0@4,   +39.09@3 44.7 24 No result unknown 
1102 36.5 667.8 2 1333.6 Tyrocidine A_analog -14.12@7,   +39.0@4,   +39.09@3 55.2 25.6 No result unknown 
1088 36.1 1333.2 1 1332.2 Tyrocidine A_analog -15.44@1,   +39.0@4,   +39.09@3 29.1 31 No result unknown 
1082 36 667 2 1332 Tyrocidine A_analog -15.64@10,   +39.0@4,   +39.09@3 27.3 25.8 No result unknown 
1244 40.4 666.9 2 1331.9 Tyrocidine A_analog -15.81@7,   +39.0@4,   +39.09@3 34.9 46.5 No result unknown 
1249 40.5 666.9 2 1331.7 Tyrocidine A_analog -15.94@10,   +39.0@4,   +39.09@3 38.7 30.8 No result unknown 
1253 40.7 666.9 2 1331.7 Tyrocidine A_analog -15.98@10,   +39.0@4,   +39.09@3 41.9 32.8 No result unknown 
1257 40.8 666.9 2 1331.7 Tyrocidine A_analog -15.99@10,   +39.0@4,   +39.09@3 37.7 33.9 No result unknown 
1035 34.6 663.4 2 1324.7 Tyrocidine A_analog -22.95@10,   +39.0@4,   +39.09@3 30 29.9 No result unknown 
1275 41.3 658.3 2 1314.5 Tyrocidine A_analog -33.13@10,   +39.0@4,   +39.09@3 56.6 26.4 No result unknown 
912 30.5 657.4 2 1312.7 Tyrocidine A_analog -34.95@10,   +39.0@4,   +39.09@3 29.9 31.1 No result unknown 
917 30.6 657.4 2 1312.7 Tyrocidine A_analog -34.98@10,   +39.0@4,   +39.09@3 28.6 27.7 No result unknown 
924 30.9 657.3 2 1312.6 Tyrocidine A_analog -35.1@3,   +39.0@4,   +39.09@3 42.1 24.3 No result unknown 
1150 37.8 681.3 2 1360.7 Tyrocidine A_analog +12.97@10,   +39.0@4,   +39.09@3 54.4 29.8 No result unknown 
1124 37.1 681.9 2 1361.8 Tyrocidine A_analog +14.14@10,   +39.0@4,   +39.09@3 34.6 40 No result unknown 
1118 37 681.9 2 1361.9 Tyrocidine A_analog +14.2@9,   +39.0@4,   +39.09@3 31.7 38.4 No result unknown 
1113 36.8 682 2 1361.9 Tyrocidine A_analog +14.26@10,   +39.0@4,   +39.09@3 31.1 37 No result unknown 
1054 35.1 682.4 2 1362.9 Tyrocidine A_analog +15.18@8,   +39.0@4,   +39.09@3 28.8 40.6 No result unknown 
968 32.3 682.8 2 1363.6 Tyrocidine A_analog +15.97@10,   +39.0@4,   +39.09@3 42.3 29.8 No result unknown 
982 32.8 682.9 2 1363.7 Tyrocidine A_analog +16.04@10,   +39.0@4,   +39.09@3 37.8 36.9 No result unknown 
977 32.6 682.9 2 1363.9 Tyrocidine A_analog +16.2@10,   +39.0@4,   +39.09@3 33.7 42.4 No result unknown 
1083 36 683.4 2 1364.7 Tyrocidine A_analog +17.03@10,   +39.0@4,   +39.09@3 33.2 31.3 No result unknown 
1070 35.6 683.7 2 1365.4 Tyrocidine A_analog +17.74@10,   +39.0@4,   +39.09@3 58 28.9 No result unknown 
1072 35.7 683.8 2 1365.6 Tyrocidine A_analog +17.97@10,   +39.0@4,   +39.09@3 61.5 33.6 No result unknown 
1202 39.3 686.4 2 1370.8 Tyrocidine A_analog +23.13@8,   +39.0@4,   +39.09@3 31.5 39 Tyrocidine D mis-localized 
1197 39.1 686.4 2 1370.9 Tyrocidine A_analog +23.19@7,   +39.0@4,   +39.09@3 31.3 45.2 Tyrocidine D correct 
1192 39 686.5 2 1370.9 Tyrocidine A_analog +23.22@8,   +39.0@4,   +39.09@3 30.6 40.1 Tyrocidine D mis-localized 
1149 37.8 688.4 2 1374.7 Tyrocidine A_analog +27.02@10,   +39.0@4,   +39.09@3 38.2 32.5 No result unknown 
923 30.8 688.4 2 1374.7 Tyrocidine A_analog +27.04@1,   +39.0@4,   +39.09@3 27.2 24.2  No result unknown 
997 33.3 694.3 2 1386.6 Tyrocidine A_analog +38.94@10,   +39.0@4,   +39.09@3 50.2 27.5 No result unknown 
992 33.2 694.3 2 1386.6 Tyrocidine A_analog +38.95@10,   +39.0@4,   +39.09@3 52.4 26.8 No result unknown 
1012 33.8 694.3 2 1386.7 Tyrocidine A_analog +39.01@10,   +39.0@4,   +39.09@3 44.8 36.7 No result unknown 
1007 33.7 694.4 2 1386.7 Tyrocidine A_analog +39.02@10,   +39.0@4,   +39.09@3 46.3 30.9 No result unknown 
1002 33.5 694.4 2 1386.7 Tyrocidine A_analog +39.04@10,   +39.0@4,   +39.09@3 29.3 29.6 No result unknown 
1120 37 694.8 2 1387.7 Tyrocidine A_analog +39.98@10,   +39.0@4,   +39.09@3 38.5 28.4 No result unknown 
Table 4.4: Identification report of the third round of analog search using tyrocidine-C
(A+39.04@4+39.25@3) as the seed.
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analogs and also the analogs’ structural information. A conclusive characterization of
the analog structure needs further experimental techniques (such as NMR). However, the





5.1 Detection of NRP Analogs with Specified Modi-
fications using Database Search
Novel NRPs can be found as analogs to a known NRP. They can have nearly identical
structure but only differ at a few monomers. A database search algorithm would be more
useful in NRP discovery if it can identify the analogs of known NRPs in the database. This
is the very incentive for creating the iSNAP analog search algorithm described in Chapter
4. As a prototype, it fulfills the objectives, but has two major drawbacks in practical use.
First, in order to have analogs identified with analog search, it requires the NRP in the
original form be identified in the initial database search. As such, analogs search is nullified
if the original form does not exist in the analyzed sample at all. Secondly, the number
of modified building blocks is limited to one in analog search. Though the analog search
algorithm can be used iteratively, it cannot find analogs with more than one difference sites,
if there is no analog with exactly one of the difference sites to intermediate the progression.
As an example, in Experiment VI, if tyrocidine-C is not in the sample, it is not possible
for the iterative analog search to find tyrocidine-D as an analog to tyrocidine-A.
The benefit of the above analog search is that we do not have to know the mass
difference on the modified site (∆m) prior to the search. If we have the knowledge of
what the possible changes are, a different search strategy can be designed. With the
input of a small set of {∆mi} (i = 1 . . . k), as well as the maximum number l (l < k)
of sites that can be modified on a database NRP, the problem becomes analogous to
the traditional database search with specified post-translational modifications[44]. The
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problem can be solved similarly. For an input tandem spectrum with precursor mass of
M , we can enumerate subcollections of {∆mi} with a maximum of l elements. For each
subcollection {∆m̂j} (1 ≤ j ≤ l̂ ≤ l,∆m̂j ∈ {∆mi}), the mass differences ∆m̂j (1 ≤ j ≤ l̂)
are exhaustively apply to database NRPs with mass around M−
∑l̂
j=1 ∆m̂j, so that analog
candidates can be generated. These candidates can be scored using the same scoring scheme
for database search.
The method is computationally intensive and definitely needs further work. However,
it does not require the original form to be in the sample and can possibly support analog
identification with a few more modified sites.
5.2 Nonribosomal Peptide Identification with Spectra
Library
Spectral library search is one of the approaches for peptide identification. It is consid-
ered to have better identification accuracy and can be faster than searching a structural
database. Assuming we have a library consisting of previously generated tandem spectra
of nonribosomal peptides, the NRP identification problem could be solved much easier.
With such a spectral library, the structural complexity of NRP is no longer an issue, all
the algorithm need to do is to match the input spectra with the spectra in the library.
Such a library search algorithm for NRPs is intrinsically the same as the library search
algorithm for linear peptides.
Specifically, using an NRP spectra can be beneficial in at least two aspects. The first is,
fragment ions generated from unexpected pathways can now be matched, and contributed
to a more reliable identification. It is specially important for NRP tandem spectra with
the presence of non-directed sequences (NDS). These ions are supposed to appear in both
the input spectra and in the library spectrum of the corresponding NRP, thus would no
longer be ”unexpected”. Secondly, library spectra have the ion intensity information as
well as the m/z value of each fragment. Hypothetical fragments used in structural database
search only have the m/z. When a fragment ion with high intensity is matched, it should
be considered more significant than a match of low intensity ions. Ion intensities, as extra
information can help evaluate the matching quality and ultimately lead to more reliable
scores.
However, NRP spectral library search is hindered by the availability of such a library.
Above all, there is no compiled spectral library with a considerable number of nonribo-
somal peptides. If we have partners in biochemical laboratories willing to collaborate on
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this project, building such a library would have great impact not only for bioinformatics
research, but also for the research of novel NRP discovery. The challenge is, there is no
ready supply of the nonribosomal peptides. Only a small number of NRPs can be ordered
from commercial suppliers. For the others, microbial fermentation will need to be done,
and the NRP need to be screened and exacted. It will take tremendous amount of work.
Moreover, a protocol need to be designed for compiling the library, which regulates the
procedure of running mass spectrometers and also the pre-process of mass spectra.
5.3 Targeted NRP Identification by Searching Database
of Predicted NRPs
As introduced in Chapter 2, it is understood that nonribosomal peptide synthetases
(NRPS), occasionally as well as polyketide synthases (PKS), are involved in the biosynthe-
sis of nonribosomal peptides. NRPS and PKS are encoded in gene clusters within microbial
genomes. These synthetases are the modules that assemble NRPs and lead to the diversity
we have seen[14].
As bioinformatics research advances, there are already software that can identify gene
clusters encoding NRPS and PKS by analyzing the genome sequence. AntiSMASH[45], for
instance, claimed to enable genome-wide rapid identification, annotation and analysis of
gene clusters for secondary metabolite biosynthesis. With such technology, NRPS and PKS
for the biosynthesis of secondary metabolites can be revealed. NRPS and PKS modules
can be translated to building blocks in the secondary metabolite, and allow researchers to
predict the molecular structure of novel NRPs.
Our research collaborators in Nathan Magarvey Lab at McMaster University perceives
a genome-wide analysis using AntiSMASH would facilitate the prediction of many novel
NRPs, which may be produced by the bacteria. These predicted NRPs could be added into
the build-in database, and then microbial fermentations cultured in varying conditions can
be screened by iSNAP. With this targeted approach, iSNAP could directly contribute to




In this work, iSNAP has been proposed as the first database search software for non-
ribosomal peptides. It has been evolved from the traditional database search approach to
be competent at handling complicated NRP structures. NRP identifications are made by
comparing the input MS/MS spectra with hypothetical fragments generated from NRPs in
the database. Significance scores P1 and P2 are calculated to indicate the confidence of an
NRP identification. Combined with an in-house structural database of 1107 NRPs, iSNAP
was tested to be an effective tool in revealing the true NRP for input MS/MS scans. Exper-
iments demonstrated that the database search algorithm could find spiked and naturally
produced NRPs within complex samples, and could distinctively identify mixed NRPs with
similar structures. Across identified MS/MS scans, the false discovery rate was tested to be
less than 7%. As such, iSNAP enables automated and high-throughput NRP dereplication
and can faciliate the discovery of novel NRPs.
Furthermore, iSNAP analog search has been developed as an extension to the NRP
database search algorithm. It is a semi-automated software to identify NRP analogs, which
are outside of the NRP database, with one building block differ from a previouly identified
NRP. iSNAP analog search is usable as an assistant tool for NRP analog deprelication and
novel analog discovery. It exposes a list of MS/MS scans for potential analogs and also the
analogs’ structural information. iSNAP provides a list of good candidates for follow-up
experiments to start with, and helps move towards the conclusive characterization of novel
NRP analogs.




A.1 iSNAP Web Service
A.1.1 User Interface of iSNAP
See Figure A.1 A.2
A.1.2 How to Use iSNAP
• Step 1: Convert mass spectral data to .mzXML
– iSNAP supports .mzXML as input, which is a standardized format for mass
spectral data. Instrument vendors usually provide free software that convert
native acquisitions to this standard format. For instance, ReAdW can be used
to convert ThermoFinnigan raw files, and CompassXport for Bruker raw files,
etc. Besides, there are also third-party efforts trying to simplify the conversion.
ProteoWizard’s msconvert supports the conversion of Agient, Bruker, Thermo,
Waters and AB Sciex file formats into mzXML.
• Step 2: Input an .mzXML file
– Click “Choose File”, and select the .mzXML file with the pop-up dialog. We
provided a test example, the LC-MS/MS data of Bacillus sp. fermentation
extract. The example data can be download by clicking the link ”Example
.mzXML file”.
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Figure A.1: User interface of iSNAP web service.
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Figure A.2: A sample identification report generated by iSNAP.
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• Step 3: Choose the database
– By default, iSNAP search with the built-in database which was assembled in-
house, contains about 1107 nonribosomal peptides. Users can also upload their
own NRPs to be included into the database for a search. These NRPs should
be encoded as SMILES code and formatted in text file with each NRP takes
one line.
• Step 4: Specify the search mode
– “Precise Search” is the default search mode. In this mode, database search
is perform with algorithm described in Chapter 3. Identifications can only be
made when the MS/MS spectrum matches an NRP in the database. In the
“Precise and Analog Search” mode, the analog search feature turned on. It
runs the analog search described in Chapter 4 after the initial “Precise Search”
is done. The size of analog search window ∆ need to be specified for analog
search.
• Step 5: Submit the task
– By simply clicking the Submit button, iSNAP will start to analyze the input
spectra and perform NRP identification. The web page should not be closed
throughout the analyzing process. The progress will be updated on the web,
until the analysis is finished.
• Step 6: Understand the identification report
– An identification report will be summarized for your inspection after iSNAP
finishes the analysis. The report is formatted in Excel spreadsheet and can
be downloaded with a link. For each MS/MS scan, NRP candidates in ±1Da
precursor mass window are listed in the report with their information and scores.
Candidates are sorted by P1 score. Both P1 and P2 scores indicate confidence
of the identification, which is explained in Chapter 3. Besides the report, a
brief summary will be displayed on the web page. The summary only shows
the identified NRPs, which are the top candidates corresponding the MS/MS
spectrum and have P1 and P2 above score thresholds.
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A.1.3 Technical Details
The iSNAP web service is developed as a Java Servlet, deployed on the Apache web
server hosted on the www-novo.cs.uwaterloo.ca. The program is designed to support simul-
taneous sessions from multiple users. It dispatches search tasks by assigning a dedicated
thread for each. In the stage of analog search, MS/MS spectra are divided into batches
and analyzed with multiple threads, making use of all available CPUs, as this step is
computationally intensive.
A.1.4 Acknowledgment
iSNAP uses following software packages as libraries.
• The Chemistry Development Kit (CDK)[46], under LGPL license.
• Java Excel API (JExcelApi), under LGPL license.
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